We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$44.4B
AUM Growth
+$4.56B
Cap. Flow
+$1.39B
Cap. Flow %
3.14%
Top 10 Hldgs %
19.07%
Holding
3,821
New
246
Increased
1,953
Reduced
1,330
Closed
177

Sector Composition

Rank Sector Weight
1 Technology 12.61%
2 Financials 5.78%
3 Consumer Discretionary 5.1%
4 Healthcare 4.99%
5 Industrials 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVFM
3601
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$17K ﹤0.01%
3,024
-1,679
-36% -$14.3K
HELP
3602
Cybin Inc
HELP
$472M
$15K ﹤0.01%
338
+17
+5% +$1.08K
ARTL icon
3603
Artelo Biosciences
ARTL
$3.56M
$14K ﹤0.01%
+102
New +$20.1K
CNSP icon
3604
CNS Pharmaceuticals
CNSP
$7.64M
0
CBIO
3605
Crescent Biopharma
CBIO
$602M
$14K ﹤0.01%
100
AQMS icon
3606
Aqua Metals
AQMS
$9.63M
$13K ﹤0.01%
56
KALA icon
3607
KALA BIO
KALA
$11.8M
$13K ﹤0.01%
5
SPPI
3608
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$13K ﹤0.01%
10,850
GTE icon
3609
Gran Tierra Energy
GTE
$260M
$12K ﹤0.01%
1,644
-105
-6% -$855
NAK
3610
Northern Dynasty Minerals
NAK
$885M
$12K ﹤0.01%
38,050
HEPA
3611
DELISTED
Hepion Pharmaceuticals
HEPA
$11K ﹤0.01%
+10
New +$13.7K
VLN.WS icon
3612
Valens Semiconductor Ltd Warrants
VLN.WS
$11K ﹤0.01%
+20,200
New +$13.1K
ASXC
3613
DELISTED
Asensus Surgical, Inc.
ASXC
$11K ﹤0.01%
10,747
-18,273
-63% -$28.2K
CATX icon
3614
Perspective Therapeutics
CATX
$332M
$10K ﹤0.01%
2,628
-1,350
-34% -$7.2K
GYRE icon
3615
Gyre Therapeutics
GYRE
$662M
$9K ﹤0.01%
1,333
UAMY icon
3616
United States Antimony
UAMY
$766M
$9K ﹤0.01%
18,790
TRVN
3617
DELISTED
Trevena, Inc.
TRVN
$8K ﹤0.01%
22
-1
-4% -$554
TRX icon
3618
TRX Gold Corp
TRX
$255M
$7K ﹤0.01%
18,500
-666
-3% -$289
RMTI icon
3619
Rockwell Medical
RMTI
$26.2M
$6K ﹤0.01%
145
DCOY
3620
Decoy Therapeutics
DCOY
$2.68M
0
RNTX
3621
Rein Therapeutics
RNTX
$67.7M
$6K ﹤0.01%
540
-10
-2% -$155
ZNB
3622
Zeta Network Group
ZNB
$64.9K
0
CRVO icon
3623
CervoMed
CRVO
$24.6M
$3K ﹤0.01%
135
SDEV
3624
Stablecoin Development Corp
SDEV
$29.8M
$3K ﹤0.01%
2
AAU
3625
DELISTED
Almaden Minerals Ltd
AAU
$3K ﹤0.01%
12,845
-10,500
-45% -$3.72K

Similar funds

Commonwealth Equity Services's Q4 2021 Portfolio in Review

As of Q4 2021, Commonwealth Equity Services held 3,821 positions worth $44.4B, up 11% from $39.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Commonwealth Equity Services deployed $1.39B of net new capital in Q4 2021, opening 246 new positions and adding to 1,953 existing holdings. Its largest new stake was First Trust Nasdaq Oil & Gas ETF: 960,334 shares worth $18.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Gold Trust, an estimated $27.2M trimmed.

  • Commonwealth Equity Services's largest Q4 2021 buy was First Trust Nasdaq Oil & Gas ETF: 960,334 shares worth $18.7M.
  • Commonwealth Equity Services added most to iShares ESG Aware MSCI USA ETF in Q4 2021, an estimated $54M increase.
  • Commonwealth Equity Services's biggest Q4 2021 reduction was iShares Gold Trust, cutting an estimated $27.2M.
  • Commonwealth Equity Services fully exited PIMCO Dynamic Credit and Mortgage Income Fund in Q4 2021, selling an estimated $9.53M.
  • Commonwealth Equity Services's ten largest holdings make up 19% of its $44.4B portfolio in Q4 2021.
  • Commonwealth Equity Services opened 246 new positions and closed 177 in Q4 2021.
  • Commonwealth Equity Services's portfolio value rose 11% quarter-over-quarter to $44.4B.

Based on Commonwealth Equity Services's 13F filing for Q4 2021, filed 31 Jan 2022.